Last updated: October 16, 2024
Sponsor: Vlasta Krausová
Overall Status: Completed
Phase
N/A
Condition
Diabetes Mellitus, Type 1
Treatment
N/AClinical Study ID
NCT05958264
310/1
Ages 3-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
type 1 diabetes mellitus
informed consent of parents
Exclusion
Exclusion Criteria:
acute infection
period of metabolic decompensation and 14 days after it
Study Design
Total Participants: 30
Study Start date:
February 01, 2023
Estimated Completion Date:
September 15, 2024
Study Description
Connect with a study center
Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
Ústí Nad Labem,
CzechiaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.